Insider Stock Trading History of Adams Brian


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Adams Brian since year 2005. The trader's CIK number is 1636994. At the time of this reporting, Adams Brian is the General Counsel and Secretary of Keryx Biopharmaceuticals Inc . (stock ticker symbol KERX). See this page for all insider trading activities at Keryx Biopharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Adams Brian since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-05 KERX Keryx Biopharmaceuticals Inc Sale 630 7.19 4,529
2017-07-31 KERX Keryx Biopharmaceuticals Inc Sale 1,445 7.14 10,317
2017-07-05 KERX Keryx Biopharmaceuticals Inc Sale 641 7.67 4,916
2017-05-01 KERX Keryx Biopharmaceuticals Inc Sale 1,441 5.97 8,602
2017-04-17 KERX Keryx Biopharmaceuticals Inc Sale 1,090 5.75 6,267
2017-04-05 KERX Keryx Biopharmaceuticals Inc Sale 642 5.80 3,723
2017-01-30 KERX Keryx Biopharmaceuticals Inc Sale 6,984 4.65 32,475
2017-01-17 KERX Keryx Biopharmaceuticals Inc Sale 1,265 6.24 7,893
2017-01-05 KERX Keryx Biopharmaceuticals Inc Sale 759 6.16 4,675
2016-10-17 KERX Keryx Biopharmaceuticals Inc Sale 1,106 4.86 5,375
2016-10-05 KERX Keryx Biopharmaceuticals Inc Sale 647 5.38 3,480
2016-07-15 KERX Keryx Biopharmaceuticals Inc Sale 1,083 7.01 7,591
2016-07-05 KERX Keryx Biopharmaceuticals Inc Sale 660 6.66 4,395
2016-04-15 KERX Keryx Biopharmaceuticals Inc Sale 1,060 5.05 5,353
2016-04-05 KERX Keryx Biopharmaceuticals Inc Sale 759 4.50 3,415
2016-01-15 KERX Keryx Biopharmaceuticals Inc Sale 1,322 3.30 4,362
2016-01-06 KERX Keryx Biopharmaceuticals Inc Sale 3,004 5.16 15,500
2015-10-15 KERX Keryx Biopharmaceuticals Inc Sale 1,011 4.01 4,054
2015-07-15 KERX Keryx Biopharmaceuticals Inc Sale 1,086 9.99 10,849
2015-04-15 KERX Keryx Biopharmaceuticals Inc Sale 4,320 12.40 53,568

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adams Brian (General Counsel and Secretary of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.